RecruitingNCT06160310
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry
Sponsor
David M. Ritter
Enrollment
300 participants
Start Date
Jul 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study is an observational registry designed to gather information about Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) in pregnant women and their child.
Eligibility
Sex: FEMALE
Plain Language Summary
Simplified for easier understanding
This registry is collecting information about pregnancies in women who have tuberous sclerosis complex (TSC) or lymphangioleiomyomatosis (LAM) — rare genetic conditions that can affect the lungs, kidneys, and other organs. The goal is to better understand how these conditions affect pregnancy and vice versa, and to guide future care.
**You may be eligible if...**
- You are pregnant
- You have a clinical or genetic diagnosis of tuberous sclerosis complex (TSC) or lymphangioleiomyomatosis (LAM)
- Or you carry a variant of uncertain significance in the TSC1 or TSC2 genes and are pregnant
- Or your baby's father has TSC and you are pregnant
**You may NOT be eligible if...**
- You are not pregnant
- You do not have TSC, LAM, or a relevant genetic variant
- You do not meet any of the listed diagnostic criteria
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06160310
Related Trials
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
NCT017995381 location
Study of the Disease Process of Lymphangioleiomyomatosis
NCT000014651 location
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT0548583118 locations
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
NCT0510498311 locations
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
NCT068891682 locations